Insider Transactions in Q1 2022 at Humanigen, Inc (HGEN)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 11
2022
|
Dale Chappell Chief Scientific Officer |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+8.62%
|
$3,000,000
$3.0 P/Share
|
|
Mar 09
2022
|
Adrian Kilcoyne Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+29.41%
|
$10,000
$2.78 P/Share
|
|
Mar 08
2022
|
Adrian Kilcoyne Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
7,000
+50.0%
|
$14,000
$2.53 P/Share
|
|
Mar 02
2022
|
Edward P. Jordan Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
12,500
+50.0%
|
$25,000
$2.32 P/Share
|
|
Mar 02
2022
|
Cameron Durrant Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
40,000
+36.36%
|
$80,000
$2.34 P/Share
|